Pfizer (NEOE:ZPFE) FFO


NEOE:ZPFE Pfizer Inc NEOE:ZPFE
57 GF Score
Price C$9.93
GF Value C$10.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer FFO?

FFO (Funds from operations) only applies to REITs.

NEOE:ZPFE
57GF Score
Pfizer Inc NEOE:ZPFE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pfizer (NEOE:ZPFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of C$9.93 is trading 6.8% below its estimated GF Value™ of C$10.65. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for NEOE:ZPFE:

  • FFO:
  • GF Value™: C$10.65 vs. price of C$9.93 (6.8% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the NEOE:ZPFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
57GF Score

Get the complete analysis for NEOE:ZPFE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$9.93
Price
C$10.65
GF Value